At a glance
ClinicalIndex Comparison RecordPhase 2Unknown· 59 target
Drug / intervention
Unity-based MR-Linac guided Radiotherapycombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Phase II Study of MR-Linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor
In Brief
A Phase 2 clinical trial evaluating Unity-based MR-Linac guided Radiotherapy for Mediastinal Tumor. Targeting 59 participants across 1 site.
Detailed Summary
This Phase II study is to determine the efficacy and safety of MR-Linac Guided Radiotherapy in patients with inoperable mediastinal tumors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMediastinal Tumor
CountriesChina
Collaborators--
Timeline
Phase 2UnknownOverdue
20222023202420252026
Enrollment StartOct 2021
First PostedDec 2021
Primary CompletionOct 2023
TodayJul 2026
First PostedDec 20, 2021
Enrollment StartOct 1, 2021
Primary CompletionOct 1, 2023
TodayJul 1, 2026
Enrollment to primary: 2 yearsPosted 4.5 years ago
Interventions
Unity-based MR-Linac guided Radiotherapycombination
The radiotherapy was delivered using the Unity-based MR-Linac treatment machine.